Europe — EMA

Olimestra (Olmesartan Medoxomil)

Olmesartan medoxomil, the active ingredient in Olimestra, is an angiotensin II receptor blocker presented as a tablet for oral use. It is used to treat high blood pressure in adults.

Olmesartan Medoxomil

Request sourcing

Pack/s

What is Olmesartan Medoxomil?

Olmesartan medoxomil, the active ingredient in Olimestra, is an angiotensin II receptor blocker presented as a tablet for oral use. It is used to treat high blood pressure in adults. GNH USA supplies Olimestra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olimestra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil used for?

Olimestra is an angiotensin‑II receptor blocker that is indicated for conditions related to the renin‑angiotensin system.

- Hypertension: helps reduce systolic and diastolic blood pressure. - Heart failure: used as part of combination therapy to improve cardiac output. - Diabetic nephropathy : may reduce the progression of kidney damage in patients with type 2 diabetes.

What are the side effects of Olmesartan Medoxomil?

Common Side Effects: - Dizziness - C C ... ... ... ... .... ... ... ... … … .... ... … …

Serious or Rare ");

What precautions apply to Olmesartan Medoxomil?

Olimestra g g t t

What does Olmesartan Medoxomil interact with?

""""" "

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →